Molecular & Integrative Physiology (MIP)

Chemical disinfection makes water from both natural sources and wastewater streams drinkable; however, the process also creates byproducts, not all of which are understood or regulated. A new study from University of Illinois Urbana-Champaign researchers has found that one byproduct disrupts...

The School of Molecular & Cellular Biology is pleased to announce the winners of its annual Undergraduate Research Symposium.

Researchers at the University of Illinois Urbana-Champaign are hopeful their findings on the gating mechanisms behind epilepsy-associated potassium channels could provide a foundation for new therapeutic strategies for treating epilepsy, especially in young patients. Their research was recently...

For the past few decades, scientists have observed a trend of increased height and younger age of puberty onset in humans. Now, research outlining a new pathway in humans linking body fat to puberty onset and growth could provide an explanation as to why these changes are occurring. Their findings...

Thanks to the installation of a cryogenic electron microscope at the University of Illinois, researchers are exploring what was once hidden or difficult to study at the molecular level.

Researchers at the University of Illinois Urbana-Champaign can now rapidly isolate and chemically characterize individual organelles within cells. The new technique tests the limits of analytical chemistry and rapidly reveals the chemical composition of organelles that control biological growth,...

Albert Feng, a passionate and beloved scholar who studied the neural basis of sound communication, has passed away.

The Department of Molecular & Integrative Physiology in the School of Molecular & Cellular Biology is pleased to welcome new faculty member Patrick Sweeney!

Researchers report that infantile spasms, a rare but serious seizure disorder in babies, appear to be the result of a molecular pathway gone awry. In their study of a mouse model of the disorder, the researchers discovered that genetic mutations associated with the disease impair a pathway that is...

A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels.